Completed
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
NCT01324505
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany